245 related articles for article (PubMed ID: 29372285)
1. Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder.
Furuta A; Yamamoto T; Suzuki Y; Gotoh M; Egawa S; Yoshimura N
Int Urogynecol J; 2018 Jul; 29(7):961-966. PubMed ID: 29372285
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of Urinary Biomarkers for Assessing Bladder Condition and Histopathology in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
Jiang YH; Jhang JF; Hsu YH; Kuo HC
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233356
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of urinary CXCL10 as a biomarker for predicting Hunner type interstitial cystitis.
Niimi A; Igawa Y; Aizawa N; Honma T; Nomiya A; Akiyama Y; Kamei J; Fujimura T; Fukuhara H; Homma Y
Neurourol Urodyn; 2018 Mar; 37(3):1113-1119. PubMed ID: 29048741
[TBL] [Abstract][Full Text] [Related]
4. Urine biomarkers in ESSIC type 2 interstitial cystitis/bladder pain syndrome and overactive bladder with developing a novel diagnostic algorithm.
Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
Sci Rep; 2021 Jan; 11(1):914. PubMed ID: 33441752
[TBL] [Abstract][Full Text] [Related]
5. Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C.
Gamper M; Viereck V; Eberhard J; Binder J; Moll C; Welter J; Moser R
Int Urogynecol J; 2013 Dec; 24(12):2049-57. PubMed ID: 23670165
[TBL] [Abstract][Full Text] [Related]
6. Can We Use Urinary Cytokine/Chemokine Analysis in Discriminating Ulcer-Type Interstitial Cystitis/Bladder Pain Syndrome?
Jiang YH; Jhang JF; Kuo HC
Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626252
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil-to-lymphocyte ratio as a promising non-invasive biomarker for symptom assessment and diagnosis of interstitial cystitis/bladder pain syndrome.
Ke H; Zhu L; Wang Q; Xu K
BMC Urol; 2023 Nov; 23(1):180. PubMed ID: 37940904
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic overlap in overactive bladder and interstitial cystitis/bladder pain syndrome: development of a new algorithm.
Ackerman AL; Lai HH; Parameshwar PS; Eilber KS; Anger JT
BJU Int; 2019 Apr; 123(4):682-693. PubMed ID: 30253040
[TBL] [Abstract][Full Text] [Related]
9. Hunner-Type (Classic) Interstitial Cystitis: A Distinct Inflammatory Disorder Characterized by Pancystitis, with Frequent Expansion of Clonal B-Cells and Epithelial Denudation.
Maeda D; Akiyama Y; Morikawa T; Kunita A; Ota Y; Katoh H; Niimi A; Nomiya A; Ishikawa S; Goto A; Igawa Y; Fukayama M; Homma Y
PLoS One; 2015; 10(11):e0143316. PubMed ID: 26587589
[TBL] [Abstract][Full Text] [Related]
10. Differences in Urodynamic Parameters Between Women With Interstitial Cystitis and/or Bladder Pain Syndrome and Severe Overactive Bladder.
Shim JS; Kang SG; Park JY; Bae JH; Kang SH; Park HS; Moon du G; Cheon J; Lee JG; Kim JJ; Oh MM
Urology; 2016 Aug; 94():64-9. PubMed ID: 27130264
[TBL] [Abstract][Full Text] [Related]
11. Urine cytokines as biomarkers for diagnosing interstitial cystitis/bladder pain syndrome and mapping its clinical characteristics.
Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1391-F1399. PubMed ID: 32281420
[TBL] [Abstract][Full Text] [Related]
12. APF, HB-EGF, and EGF biomarkers in patients with ulcerative vs. non-ulcerative interstitial cystitis.
Zhang CO; Li ZL; Kong CZ
BMC Urol; 2005 Apr; 5():7. PubMed ID: 15862132
[TBL] [Abstract][Full Text] [Related]
13. Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis--Different Mechanisms of Action of Botox on Bladder Dysfunction?
Kuo YC; Kuo HC
Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26999201
[TBL] [Abstract][Full Text] [Related]
14. Elevation of serum c-reactive protein in patients with OAB and IC/BPS implies chronic inflammation in the urinary bladder.
Chung SD; Liu HT; Lin H; Kuo HC
Neurourol Urodyn; 2011 Mar; 30(3):417-20. PubMed ID: 21284020
[TBL] [Abstract][Full Text] [Related]
15. Urine nerve growth factor (NGF) level, bladder nerve staining and symptom/problem scores in patients with interstitial cystitis.
Tonyali S; Ates D; Akbiyik F; Kankaya D; Baydar D; Ergen A
Adv Clin Exp Med; 2018 Feb; 27(2):159-163. PubMed ID: 29521057
[TBL] [Abstract][Full Text] [Related]
16. A multiplexed analysis approach identifies new association of inflammatory proteins in patients with overactive bladder.
Ma E; Vetter J; Bliss L; Lai HH; Mysorekar IU; Jain S
Am J Physiol Renal Physiol; 2016 Jul; 311(1):F28-34. PubMed ID: 27029431
[TBL] [Abstract][Full Text] [Related]
17. Urinary nerve growth factor correlates with the severity of urgency and pain.
Kim SW; Im YJ; Choi HC; Kang HJ; Kim JY; Kim JH
Int Urogynecol J; 2014 Nov; 25(11):1561-7. PubMed ID: 24866276
[TBL] [Abstract][Full Text] [Related]
18. Development of an interstitial cystitis risk score for bladder permeability.
Lamb LE; Janicki JJ; Bartolone SN; Peters KM; Chancellor MB
PLoS One; 2017; 12(10):e0185686. PubMed ID: 29088231
[TBL] [Abstract][Full Text] [Related]
19. Effect of Sacral Neuromodulation on Outcome Measures and Urine Chemokines in Interstitial Cystitis/Painful Bladder Syndrome Patients.
Peters KM; Jayabalan N; Bui D; Killinger K; Chancellor M; Tyagi P
Low Urin Tract Symptoms; 2015 May; 7(2):77-83. PubMed ID: 26663686
[TBL] [Abstract][Full Text] [Related]
20. Urinary nerve growth factor could be a biomarker for interstitial cystitis/painful bladder syndrome: a meta-analysis.
Qu HC; Zhang W; Yan S; Liu YL; Wang P
PLoS One; 2014; 9(9):e106321. PubMed ID: 25181532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
